|
1
|
Vallance P, Leone A, Calver A, Collier J
and Moncada S: Accumulation of an endogenous inhibitor of nitric
oxide synthesis in chronic renal failure. Lancet. 339:572–575.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Konya H, Miuchi M, Satani K, Matsutani S,
Yano Y, Tsunoda T, Ikawa T, Matsuo T, Ochi F, Kusunoki Y, et al:
Asymmetric dimethylarginine, a biomarker of cardiovascular
complications in diabetes mellitus. World J Exp Med. 5:110–119.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Böger RH, Maas R, Schulze F and Schwedhelm
E: Asymmetric dimethylarginine (ADMA) as a prospective marker of
cardiovascular disease and mortality-an update on patient
populations with a wide range of cardiovascular risk. Pharmacol
Res. 60:481–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Landim MB, Filho A Casella and Chagas AC:
Asymmetric dimethylarginine (ADMA) and endothelial dysfunction:
Implications for atherogenesis. Clinics. 64:471–478. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schnabel R, Blankenberg S, Lubos E,
Lackner KJ, Rupprecht HJ, Espinola-Klein C, Jachmann N, Post F,
Peetz D, Bickel C, et al: Asymmetric dimethylarginine and the risk
of cardiovascular events and death in patients with coronary artery
disease: Results from the AtheroGene Study. Circ Res. 97:e53–e59.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu TM, Ding YA, Charng MJ and Lin SJ:
Asymmetrical dimethylarginine: A novel risk factor for coronary
artery disease. Clin Cardiol. 26:458–464. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J, Zhang Z, Lv L, Qiao H, Chen X and
Zou C: (−)-epigallocatechin gallate inhibits asymmetric
dimethylarginine-induced injury in human brain microvascular
endothelial cells. Neurochem Res. 41:1868–1876. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma J, Zhao S, Gao G, Chang H, Ma P and Jin
B: probucol protects against asymmetric dimethylarginine-induced
apoptosis in the cultured human brain microvascular endothelial
cells. J Mol Neurosci. 57:546–553. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Walter P and Ron D: The unfolded protein
response: From stress pathway to homeostatic regulation. Science.
334:1081–1086. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Woehlbier U and Hetz C: Modulating stress
responses by the UPRosome: a matter of life and death. Trends in
Biochem Sci. 36:329–337. 2011. View Article : Google Scholar
|
|
11
|
Zarain-Herzberg A, Garcia-Rivas G and
Estrada-Aviles R: Regulation of SERCA pumps expression in diabetes.
Cell Calcium. 56:302–310. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brini M, Cali T, Ottolini D and Carafoli
E: The plasma membrane calcium pump in health and disease. FEBS J.
280:5385–5397. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fu S, Yang L, Li P, Hofmann O, Dicker L,
Hide W, Lin X, Watkins SM, Ivanov AR and Hotamisligil GS: Aberrant
lipid metabolism disrupts calcium homeostasis causing liver
endoplasmic reticulum stress in obesity. Nature. 473:528–531. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li W, Ouyang Z, Zhang Q, Wang L, Shen Y,
Wu X, Gu Y, Shu Y, Yu B, Wu X, et al: SBF-1 exerts strong
anticervical cancer effect through inducing endoplasmic reticulum
stress-associated cell death via targeting sarco/endoplasmic
reticulum Ca(2+)-ATPase 2. Cell Death Dis. 5:e15812014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Periasamy M and Kalyanasundaram A: SERCA
pump isoforms: Their role in calcium transport and disease. Muscle
Nerve. 35:430–442. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lipskaia L, Keuylian Z, Blirando K,
Mougenot N, Jacquet A, Rouxel C, Sghairi H, Elaib Z, Blaise R,
Adnot S, et al: Expression of sarco (endo) plasmic reticulum
calcium ATPase (SERCA) system in normal mouse cardiovascular
tissues, heart failure and atherosclerosis. Biochim Biophys Acta.
1843:2705–2718. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mountian I, Manolopoulos VG, De SH, Parys
JB, Missiaen L and Wuytack F: Expression patterns of
sarco/endoplasmic reticulum Ca(2+)-ATPase and inositol
1,4,5-trisphosphate receptor isoforms in vascular endothelial
cells. Cell Calcium. 25:371–380. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Anger M, Samuel JL, Marotte F, Wuytack F,
Rappaport L and Lompré AM: In situ mRNA distribution of sarco
(endo)plasmic reticulum Ca (2+)-ATPase isoforms during ontogeny in
the rat. J Mol Cell Cardiol. 26:1–550. 1994. View Article : Google Scholar
|
|
19
|
Valkonen VP, Päivä H, Salonen JT, Lakka
TA, Lehtimäki T, Laakso J and Laaksonen R: Risk of acute coronary
events and serum concentration of asymmetrical dimethylarginine.
Lancet. 358:2127–2128. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nicholls SJ, Wang Z, Koeth R, Levison B,
DelFraino B, Dzavik V, Griffith OW, Hathaway D, Panza JA, Nissen
SE, et al: Metabolic profiling of arginine and nitric oxide
pathways predicts hemodynamic abnormalities and mortality in
patients with cardiogenic shock after acute myocardial infarction.
Circulation. 116:2315–2324. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tousoulis D, Bouras G, Antoniades C,
Marinou K, Papageorgiou N, Miliou A, Hatzis G, Stefanadi E,
Tsioufis C and Stefanadis C: Methionine-induced homocysteinemia
impairs endothelial function in hypertensives: The role of
asymmetrical dimethylarginine and antioxidant vitamins. Am J
Hypertens. 24:936–942. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park MJ, Oh KS, Nho JH, Kim GY and Kim DI:
Asymmetric dimethylarginine (ADMA) treatment induces apoptosis in
cultured rat mesangial cells via endoplasmic reticulum stress
activation. Cell Biol Int. 40:662–670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hong D, Gao HC, Wang X, Li LF, Li CC, Luo
Y, Wang KK, Bai YP and Zhang GG: Asymmetric dimethylarginine
triggers macrophage apoptosis via the endoplasmic reticulum stress
pathway. Mol Cell Biochem. 398:31–38. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Leng YP, Qiu N, Fang WJ, Zhang M, He ZM
and Xiong Y: Involvement of increased endogenous asymmetric
dimethylarginine in the hepatic endoplasmic reticulum stress of
type 2 diabetic rats. PLoS One. 9:e971252014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo W, Ding J, Zhang A, Dai W, Liu S, Diao
Z, Wang L, Han X and Liu W: The inhibitory effect of quercetin on
asymmetric dimethylarginine-induced apoptosis is mediated by the
endoplasmic reticulum stress pathway in glomerular endothelial
cells. Int J Mol Sci. 15:484–503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou QG, Zhou M, Hou FF and Peng X:
Asymmetrical dimethylarginine triggers lipolysis and inflammatory
response via induction of endoplasmic reticulum stress in cultured
adipocytes. Am J Physiol Endocrinol Metab. 296:E869–E878. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lim SK, Choi H, Park MJ, Kim DI, Kim JC,
Kim GY, Jeong SY, Rodionov RN, Han HJ, Yoon KC and Park SH: The ER
stress-mediated decrease in DDAH1 expression is involved in
formaldehyde-induced apoptosis in lung epithelial cells. Food Chem
Toxicol. 62:763–769. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lundman P, Eriksson MJ, Stühlinger M,
Cooke JP, Hamsten A and Tornvall P: Mild-to-moderate
hypertriglyceridemia in young men is associated with endothelial
dysfunction and increased plasma concentrations of asymmetric
dimethylarginine. J Am Coll Cardiol. 38:111–116. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Surdacki A, Nowicki M, Sandmann J, Tsikas
D, Boeger RH, Bode-Boeger SM, Kruszelnicka-Kwiatkowska O, Kokot F,
Dubiel JS and Froelich JC: Reduced urinary excretion of nitric
oxide metabolites and increased plasma levels of asymmetric
dimethylarginine in men with essential hypertension. J Cardiovasc
Pharmacol. 33:652–658. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Alpoim PN, Sousa LP, Mota AP, Rios DR and
Dusse LM: Asymmetric dimethylarginine (ADMA) in cardiovascular and
renal disease. Clin Chim Acta. 440:1–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tousoulis D, Georgakis MK, Oikonomou E,
Papageorgiou N, Zaromitidou M, Latsios G, Papaioannou S and Siasos
G: Asymmetric dimethylarginine: Clinical significance and novel
therapeutic approaches. Curr Med Chem. 22:2871–2901. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Santilli F, Liani R, Di Fulvio P, Formoso
G, Simeone P, Tripaldi R, Ueland T, Aukrust P and Davì G: Increased
circulating resistin is associated with insulin resistance,
oxidative stress and platelet activation in type 2 diabetes
mellitus. Thromb Haemost. 116:1089–1099. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kielstein JT, Böger RH, Bode-Böger SM,
Schäffer J, Barbey M, Koch KM and Frölich JC: Asymmetric
dimethylarginine plasma concentrations differ in patients with
end-stage renal disease: Relationship to treatment method and
atherosclerotic disease. J Am Soc Nephrol. 10:594–600.
1999.PubMed/NCBI
|
|
34
|
Wang LY, Zhang DL, Zheng JF, Zhang Y,
Zhang QD and Liu WH: Apelin-13 passes through the ADMA-damaged
endothelial barrier and acts on vascular smooth muscle cells.
Peptides. 32:2436–2443. 2011. View Article : Google Scholar : PubMed/NCBI
|
